Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Hold
342
0.01% 262
2025
Q4
$107K Hold
342
0.01% 236
2025
Q3
$92.4K Sell
342
-32
-9% -$7.33K 0.01% 223
2025
Q2
$82.5K Hold
374
0.01% 228
2025
Q1
$49.1K Hold
374
0.01% 326
2024
Q4
$51.3K Buy
374
+302
+419% +$41.5K 0.01% 302
2024
Q3
$7.3K Sell
72
-302
-81% -$23.9K ﹤0.01% 694
2024
Q2
$27.4K Hold
374
﹤0.01% 391
2024
Q1
$18.9K Buy
374
+302
+419% +$14.2K ﹤0.01% 471
2023
Q4
$3.37K Buy
+72
New +$3.28K ﹤0.01% 755
2019
Q4
Sell
-217
Closed -$9K 630
2019
Q3
$9K Hold
217
﹤0.01% 360
2019
Q2
$11K Hold
217
0.01% 302
2019
Q1
$11K Buy
+217
New +$9.77K 0.01% 302

Other funds holding AGX

McIlrath & Eck's AGX Position: Q1 2026 in Review

McIlrath & Eck held its Argan (AGX) position steady in Q1 2026 at 342 shares worth $186K. The position accounts for 0.01% of the portfolio, ranked #262.

McIlrath & Eck first reported a position in AGX in Q1 2019 and has held it in 13 quarters since. 495 funds tracked by Wall St. Rank hold AGX as of Q1 2026.

  • McIlrath & Eck held 342 shares of Argan worth $186K as of Q1 2026.
  • McIlrath & Eck left its Argan share count unchanged in Q1 2026.
  • Argan made up 0.01% of McIlrath & Eck's portfolio in Q1 2026, its #262 holding.
  • McIlrath & Eck first reported a position in Argan in Q1 2019 and has held it in 13 quarters since.
  • 495 funds tracked by Wall St. Rank held Argan as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.